there were over 73,000 tick-borne disease cases here in the keystone state between 2004 and 2016.
.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
.
.
.
.